Related Experiment Videos
Methemoglobinemia from topical benzocaine
Cleveland Clinic Journal of Medicine
|June 1, 1990
Summary
Benzocaine can cause acute toxic methemoglobinemia, a serious condition leading to cyanosis, after medical procedures like esophagogastroduodenoscopy. Prompt diagnosis and treatment with oxygen and methylene blue are crucial for patient recovery.
Area of Science:
- Anesthesiology
- Toxicology
- Emergency Medicine
Background:
- Benzocaine is a common topical anesthetic used in procedures like esophagogastroduodenoscopy.
- Adverse reactions to local anesthetics, though rare, require prompt recognition and management.
Observation:
- A patient developed acute cyanosis and methemoglobinemia after topical benzocaine application and partial ingestion during an esophagogastroduodenoscopy.
- Symptoms included cyanosis and potential neurologic symptoms.
Findings:
- The case highlights acute toxic methemoglobinemia as a potential complication of benzocaine use.
- Diagnosis relies on clinical presentation (cyanosis without cardiopulmonary disease) and laboratory confirmation of elevated methemoglobin levels.
- Laboratory tests should include oxygen saturation and methemoglobin concentration.
Implications:
- Clinicians should consider methemoglobinemia in patients presenting with cyanosis post-local anesthetic use.
- Prompt management with supplemental oxygen and intravenous methylene blue is essential for reversing methemoglobinemia and improving outcomes.
- This case underscores the importance of awareness regarding benzocaine-induced methemoglobinemia in procedural sedation and local anesthesia.